Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Getong Tongluo Capsule for Recovery-Phase Ischemic Stroke
ChiCTR2600127785Phase 4Not yet recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jul 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Getong Tongluo Capsule with Placebo (2 arms). Primary endpoints: Incidence of adverse events and Distribution of mRS scores after 6 months of treatment. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
getong tongluo
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2600127785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127785.